T1-201 myocardial perfusion scintigraphy has been widely utilized for non- invasive evaluation of coronary artery disease (CAD). Extensive research and development by our group and others has resulted in the development of objective methods for analysis of images and single photon emission computerized tomography (SPECT). Nevertheless, quantitative Tl-201 SPECT has not yet reached its full potential because of suboptimal physical characteristics of the Tl-201 agent. Recently, Technetium-99m labeled Methoxy Isobutyl Isonitrile (Tc-MIBI) has been developed which obviates most of the unfavorable characteristics of Tl-201. The overall objective of this proposal is to develop, validate and assess clinical applications of a noninvasive method for quantitative assessment of myocardial perfusion using Tc-MIBI SPECT. This overall objective is addressed in two separate sections. I. Relative Quantitation of Myocardial Perfusion: The long term objective of this section is to develop, optimize and validate methods for acquisition, filtering, reconstruction, quantitative analysis, and displaying Tc-MIBI SPECT data. The hypothesis to be tested is whether relative quantitation (determination of the volume of abnormally perfused myocardium) of Tc-MIBI Spect data can be implemented in patient studies in a manner in which they will more accurately predict quantitative coronary angiographic findings and the presence and size of perfusion defects. II. Absolute Quantitation of Myocardial Perfusion: The long-term objective of this section is to develop methods to obtain, in the clinical setting, a linear relation between pixel count values and myocardial tracer concentrations and thus obtain truly quantitative imaging. This should result in improved uniformity of normal tissue count distribution, increased lesion contrast and measurement of actual myocardial blood flow. On order to fulfill this objective it is necessary to apply corrections for: Compton Scatter, attenuation and object size of the myocardium due to finite resolution effects.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL041628-01A1
Application #
3359456
Study Section
Cardiovascular Study Section (CVA)
Project Start
1989-08-01
Project End
1992-07-31
Budget Start
1989-08-01
Budget End
1990-07-31
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
Maddahi, J; Rodrigues, E; Berman, D S et al. (1994) State-of-the-art myocardial perfusion imaging. Cardiol Clin 12:199-222
Van Train, K F; Garcia, E V; Maddahi, J et al. (1994) Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99m-sestamibi myocardial tomograms. J Nucl Med 35:609-18
Garcia, E V (1994) Quantitative myocardial perfusion single-photon emission computed tomographic imaging: quo vadis? (Where do we go from here?). J Nucl Cardiol 1:83-93
Van Train, K F; Areeda, J; Garcia, E V et al. (1993) Quantitative same-day rest-stress technetium-99m-sestamibi SPECT: definition and validation of stress normal limits and criteria for abnormality. J Nucl Med 34:1494-502
Galt, J R; Cullom, S J; Garcia, E V (1992) SPECT quantification: a simplified method of attenuation and scatter correction for cardiac imaging. J Nucl Med 33:2232-7
Maddahi, J; Kiat, H; Berman, D S (1991) Myocardial perfusion imaging with technetium-99m-labeled agents. Am J Cardiol 67:27D-34D
Berman, D S; Kiat, H; Van Train, K et al. (1991) Technetium 99m sestamibi in the assessment of chronic coronary artery disease. Semin Nucl Med 21:190-212
Maddahi, J; Kiat, H; Van Train, K F et al. (1990) Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease. Am J Cardiol 66:55E-62E
Garcia, E V; Cooke, C D; Van Train, K F et al. (1990) Technical aspects of myocardial SPECT imaging with technetium-99m sestamibi. Am J Cardiol 66:23E-31E